Related Experiment Videos
Postsurgical pelvis: treatment follow-up
Kazuro Sugimura1, Hiromi Okizuka
1Department of Radiology, Kobe University Graduate School of Medicine, Japan. sugimura@kobe-u.ac.jp
Radiologic Clinics of North America
|July 16, 2002
Summary
Detecting gynecologic cancer recurrence after treatment is crucial. Advanced imaging like MRI and CT scans help identify treatable local disease, guiding further patient therapy options.
Area of Science:
- Oncology
- Radiology
- Gynecology
Background:
- Post-treatment surveillance for gynecologic malignancies is essential for patient management.
- Radical hysterectomy, chemotherapy, and radiation therapy are common treatment modalities.
- Identifying recurrence and complications impacts subsequent treatment decisions.
Purpose of the Study:
- To review current imaging modalities for detecting gynecologic cancer recurrence.
- To assess the role of imaging in guiding treatment changes for gynecologic malignancies.
- To present imaging findings in uterine and ovarian cancer patients post-definitive treatment.
Main Methods:
- Review of magnetic resonance (MR) imaging and computed tomography (CT) techniques.
- Analysis of imaging findings in patients with uterine and ovarian cancers.
- Correlation of imaging results with treatment outcomes.
Main Results:
- MR imaging and CT are valuable for detecting local disease recurrence.
- Imaging evidence of limited recurrence can identify potentially curable disease.
- Specific imaging findings aid in treatment modification for gynecologic cancers.
Conclusions:
- Imaging plays a critical role in managing gynecologic malignancies post-treatment.
- Early detection of recurrence through imaging allows for timely adjuvant therapies.
- Modalities like MR imaging and CT are indispensable for treatment planning.